Your browser doesn't support javascript.
loading
Human mutations in SLITRK3 implicated in GABAergic synapse development in mice.
Efthymiou, Stephanie; Han, Wenyan; Ilyas, Muhammad; Li, Jun; Yu, Yichao; Scala, Marcello; Malintan, Nancy T; Ilyas, Muhammad; Vavouraki, Nikoleta; Mankad, Kshitij; Maroofian, Reza; Rocca, Clarissa; Salpietro, Vincenzo; Lakhani, Shenela; Mallack, Eric J; Palculict, Timothy Blake; Li, Hong; Zhang, Guojun; Zafar, Faisal; Rana, Nuzhat; Takashima, Noriko; Matsunaga, Hayato; Manzoni, Claudia; Striano, Pasquale; Lythgoe, Mark F; Aruga, Jun; Lu, Wei; Houlden, Henry.
Affiliation
  • Efthymiou S; Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
  • Han W; U.O.C. Genetica Medica, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genoa, Italy.
  • Ilyas M; Synapse and Neural Circuit Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
  • Li J; Department of Biological Sciences, International Islamic University Islamabad, Islamabad, Pakistan.
  • Yu Y; Synapse and Neural Circuit Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
  • Scala M; Centre for Advanced Biomedical Imaging, Division of Medicine, University College London, London, United Kingdom.
  • Malintan NT; Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
  • Ilyas M; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, Università Degli Studi di Genova, Genoa, Italy.
  • Vavouraki N; Pediatric Neurology and Muscular Diseases Unit, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Giannina Gaslini, Genoa, Italy.
  • Mankad K; Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
  • Maroofian R; Centre for Omic Sciences, Islamia College Peshawar, Peshawar, Pakistan.
  • Rocca C; School of Pharmacy, University of Reading, Reading, United Kingdom.
  • Salpietro V; Department of Mathematics and Statistics, University of Reading, Reading, United Kingdom.
  • Lakhani S; Department of Radiology, Great Ormond Street Hospital, London, United Kingdom.
  • Mallack EJ; Developmental Neurosciences Department, University College London (UCL) Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Palculict TB; Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
  • Li H; Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
  • Zhang G; Department of Neuromuscular Disorders, University College London (UCL) Queen Square Institute of Neurology, London, United Kingdom.
  • Zafar F; Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, United States.
  • Rana N; Center for Neurogenetics, Feil Family Brain and Mind Research Institute, Weill Cornell Medicine, New York, NY, United States.
  • Takashima N; GeneDx, Gaithersburg, MD, United States.
  • Matsunaga H; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States.
  • Manzoni C; Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, United States.
  • Striano P; Department of Pediatric Neurology, Children's Healthcare of Atlanta, Atlanta, GA, United States.
  • Lythgoe MF; Department of Pediatrics, Multan Hospital, Multan, Pakistan.
  • Aruga J; Department of Pediatrics, Multan Hospital, Multan, Pakistan.
  • Lu W; Laboratory for Behavioral and Developmental Disorders, RIKEN Brain Science Institute (BSI), Saitama, Japan.
  • Houlden H; Department of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences, Nagasaki, Japan.
Front Mol Neurosci ; 17: 1222935, 2024.
Article in En | MEDLINE | ID: mdl-38495551
ABSTRACT
This study reports on biallelic homozygous and monoallelic de novo variants in SLITRK3 in three unrelated families presenting with epileptic encephalopathy associated with a broad neurological involvement characterized by microcephaly, intellectual disability, seizures, and global developmental delay. SLITRK3 encodes for a transmembrane protein that is involved in controlling neurite outgrowth and inhibitory synapse development and that has an important role in brain function and neurological diseases. Using primary cultures of hippocampal neurons carrying patients' SLITRK3 variants and in combination with electrophysiology, we demonstrate that recessive variants are loss-of-function alleles. Immunostaining experiments in HEK-293 cells showed that human variants C566R and E606X change SLITRK3 protein expression patterns on the cell surface, resulting in highly accumulating defective proteins in the Golgi apparatus. By analyzing the development and phenotype of SLITRK3 KO (SLITRK3-/-) mice, the study shows evidence of enhanced susceptibility to pentylenetetrazole-induced seizure with the appearance of spontaneous epileptiform EEG as well as developmental deficits such as higher motor activities and reduced parvalbumin interneurons. Taken together, the results exhibit impaired development of the peripheral and central nervous system and support a conserved role of this transmembrane protein in neurological function. The study delineates an emerging spectrum of human core synaptopathies caused by variants in genes that encode SLITRK proteins and essential regulatory components of the synaptic machinery. The hallmark of these disorders is impaired postsynaptic neurotransmission at nerve terminals; an impaired neurotransmission resulting in a wide array of (often overlapping) clinical features, including neurodevelopmental impairment, weakness, seizures, and abnormal movements. The genetic synaptopathy caused by SLITRK3 mutations highlights the key roles of this gene in human brain development and function.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Mol Neurosci Year: 2024 Document type: Article Affiliation country: Reino Unido

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Mol Neurosci Year: 2024 Document type: Article Affiliation country: Reino Unido